{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zeng Q"],"funding":["Science and Technology Development Program of Jinan Municipal Health Commission"],"pagination":["43735"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12700950"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(1)"],"pubmed_abstract":["To construct a non-invasive and convenient early diagnostic model by integrating multidimensional clinical data and platelet (PLT) indices, and to explore the predictive value of PLT for severe Retinopathy of Prematurity (ROP). A study included premature infants admitted to our hospital from January 2020 to September 2025. According to the results of fundus screening, subjects were divided into the ROP group (n = 190) and the normal control group (n = 142). The ROP group was further categorized into mild (n = 110) and severe (n = 15) subgroups based on treatment requirements, which included platelet data corresponding to a postmenstrual age (PMA) of 30 weeks. Clinical data on parental factors, neonatal factors, and treatment factors were collected, along with PLT results from birth to PMA "],"journal":["Scientific reports"],"pubmed_title":["Development of a non-invasive diagnostic model for severe Retinopathy of Prematurity integrating clinical and platelet data."],"pmcid":["PMC12700950"],"funding_grant_id":["2024308009"],"pubmed_authors":["Li Y","Zeng Q","Lv X","Wu D","Wang J","Liu G"],"additional_accession":[]},"is_claimable":false,"name":"Development of a non-invasive diagnostic model for severe Retinopathy of Prematurity integrating clinical and platelet data.","description":"To construct a non-invasive and convenient early diagnostic model by integrating multidimensional clinical data and platelet (PLT) indices, and to explore the predictive value of PLT for severe Retinopathy of Prematurity (ROP). A study included premature infants admitted to our hospital from January 2020 to September 2025. According to the results of fundus screening, subjects were divided into the ROP group (n = 190) and the normal control group (n = 142). The ROP group was further categorized into mild (n = 110) and severe (n = 15) subgroups based on treatment requirements, which included platelet data corresponding to a postmenstrual age (PMA) of 30 weeks. Clinical data on parental factors, neonatal factors, and treatment factors were collected, along with PLT results from birth to PMA ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-06-06T02:03:32.333Z","creation":"2026-05-24T03:12:19.127Z"},"accession":"S-EPMC12700950","cross_references":{"pubmed":["41387755"],"doi":["10.1038/s41598-025-28293-y"]}}